The US health care market faces transformative changes in 2025, as biosimilars, GLP-1s, and new pharmacy economics reshape how benefit managers balance innovation with affordability.
Sharon Faust, PharmD
Advertisement
Articles by Sharon Faust, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy
2
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
3
FDA Approves Blenrep for Treatment of Relapsed or Refractory Multiple Myeloma
4
Hormone Therapy Use, Understanding, and Perceptions Have Positively Shifted From 2021 to 2025
5
